Exhibit 25.1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORMT-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939
OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE
☐ | CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) |
THE BANK OF NEW YORK MELLON
(Exact name of trustee as specified in its charter)
| | |
New York | | 13-5160382 |
(Jurisdiction of incorporation if not a U.S. national bank) | | (I.R.S. employer identification no.) |
| |
225 Liberty Street, New York, N.Y. | | 10286 |
(Address of principal executive offices) | | (Zip code) |
TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V.
(Exact name of obligor as specified in its charter)
| | |
Netherlands | | Not Applicable |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. employer identification no.) |
| |
Piet Heinkade 107 1019 GM Amsterdam, Netherlands | | |
(Address of principal executive offices) | | (Zip code) |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
(Exact name of obligor as specified in its charter)
| | |
Israel | | Not Applicable |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. employer identification no.) |
| |
5 Basel Street P.O. Box 3190 Petach Tikva, 4951033 Israel | | |
(Address of principal executive offices) | | (Zip code) |
3.250% Senior Notes due 2022
Guarantees of 3.250% Senior Notes due 2022
4.500% Senior Notes due 2025
Guarantees of 4.500% Senior Notes due 2025
(Title of the indenture securities)